Perceptive Advisors LLC Immatics N.V. Transaction History
Perceptive Advisors LLC
- $3 Billion
- Q4 2024
A detailed history of Perceptive Advisors LLC transactions in Immatics N.V. stock. As of the latest transaction made, Perceptive Advisors LLC holds 9,383,456 shares of IMTX stock, worth $46.9 Million. This represents 2.23% of its overall portfolio holdings.
Number of Shares
9,383,456
Previous 8,086,159
16.04%
Holding current value
$46.9 Million
Previous $92.3 Million
27.69%
% of portfolio
2.23%
Previous 2.41%
Shares
5 transactions
Others Institutions Holding IMTX
# of Institutions
93Shares Held
92.5MCall Options Held
313KPut Options Held
377K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.6MShares$53 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA10.4MShares$52.1 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$36.4 Million0.57% of portfolio
-
Rtw Investments, LP New York, NY6.54MShares$32.7 Million0.76% of portfolio
-
Vestal Point Capital, LP New York, NY6.28MShares$31.4 Million2.65% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $381M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...